Evidence map›Paper›PMID 40429538›Full record

ArticleJournal of clinical medicine2025

Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50.

Ari Raphael, Ayelet Kamm Feldman, Irina Lazarev, Waleed Kian, Nir Peled, Keren Hod, Walid Shalata, Elizabeth Dudnik

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ari RaphaelDavidoff Cancer Center, Rabin Medical Center, Petah-Tikva 4941492, Israel.ORCID 0009-0005-4024-9673
Ayelet Kamm FeldmanGoldman School of Medicine, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.
Irina LazarevGoldman School of Medicine, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.
Waleed KianDepartment of Oncology, Assuta Ashdod Medical Center, Ashdod 7747629, Israel.ORCID 0000-0003-4956-9364
Nir PeledDepartment of Oncology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Keren HodDepartment of Nutrition Sciences, School of Health Sciences, Ariel University, Ariel 4070000, Israel.
Walid ShalataDepartment of Oncology, Soroka Medical Center, Beer Sheva 8410501, Israel.ORCID 0000-0002-7570-4550
Elizabeth DudnikGoldman School of Medicine, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0000-0001-6971-3576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced non-small cell lung carcinoma (aNSCLC)biomarkershigh PD-L1lung immune prognostic index (LIPI)pembrolizumab

Identifiers

PMID40429538
PMCPMC12112323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.